Pall, Kaneka Enter Agreement

News   Jan 20, 2016

 
Pall, Kaneka Enter Agreement
 
 
 

RELATED ARTICLES

Integrated Lead Discovery: An Evolving Toolbox

News

A new SLAS Discovery review article offers an informative guide to the established and emerging tools available for early drug discovery and screening, and provides illustrative scenarios demonstrating considerations that drive decisions on choice of lead discovery tactics.

READ MORE

The Friedrich Schiller University Jena Partners with ACD/Labs to Advance its Analytical Data Management Strategy

News

Implementation of ACD/Spectrus as an analytical data management system helps researchers and students streamline NMR and MS data processing, interpretation, collaboration, and training.

READ MORE

Novel Microplate 3D Bioprinting Platform for Engineering Muscle and Tendon Tissues

News

There is a strong need for medication that treats age-related degenerative muscle and tendon diseases. A critical bottleneck in the discovery and development of novel drugs for skeletal muscle is the lack of efficient and robust functional in vitro assays for compound screening. Researchers describe the development of a novel screening platform with automated production of 3D muscle- and tendon–like tissues using 3D bioprinting.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy